Ajou University repository

Bioorganic & Medicinal Chemistry Letters
ISSN
  • E1464-3405
  • P0960-894X
Publisher

Pergamon Press Ltd.

Listed on
(Coverage)

JCR1997-2023

SJR1999-2020;2022-2023

CiteScore2011-2023

SCI2010-2019

SCIE2010-2024

CC2016-2024

SCOPUS2017-2024

MEDLINE2016-2024

EMBASE2016-2024

Active
Active

based on the information

  • SCOPUS:2024-10
Country
ENGLAND
Aime & Scopes
Bioorganic & Medicinal Chemistry Letters publishes research communications of outstanding significance and timeliness on topics at the interface of chemistry and biology, together with invited concise review articles. The journal publishes reports of experimental results in medicinal chemistry, chemical biology and drug discovery and design, emphasizing new and emerging advances and concepts in these fields. The aim of the journal is to promote a better understanding at the molecular level of life processes, and living organisms, as well as the interaction of these with chemical agents. The journal continues to be a major forum for the first publication of new chemical entities prior to them entering clinical trials. The Journal welcomes papers on: /// the medicinal chemistry and associated biology (including target identification and validation) of established or new disease targets /// the reporting of the discovery, design or optimization of potent new compounds or biological agents /// the analysis and discussion of structure-activity relationships and pharmacological issues relevant to drug design and action using in vitro and in vivo models, including the use of computational techniques when closely linked to experimental data /// the reporting of "first-in-class" new therapeutic compounds /// the chemical biology or bioorganic/bioinorganic chemistry that significantly advances knowledge of a biological mechanism /// methodological advances that are chemistry-based and which significantly impact on medicine or biology /// the preparation and examination of biotherapeutics for the treatment of pathophysiological disease states /// the development of materials for specific therapeutic targeting
Article List

Showing results 1 to 4 of 4

Synthesis of 1-(4-(dimethylamino)phenyl)-3,4-diphenyl-1H-pyrrole-2,5-dione analogues and their anti-inflammatory activities in lipopolysaccharide-induced BV2 cells
  • Jung, Hyo Jae;
  • Cho, Duk Yeon;
  • Han, Jun Hyuk;
  • Park, Ki Dong;
  • Choi, Dong Kug;
  • Kim, Eunha;
  • Yoon, Sung Hwa;
  • Park, Ju Young
  • 2023-08-15
  • Bioorganic and Medicinal Chemistry Letters, Vol.92
  • Elsevier Ltd
Synthesis of 4-(3-oxo-3-phenylpropyl)morpholin-4-ium chloride analogues and their inhibitory activities of nitric oxide production in lipopolysaccharide-induced BV2 cells
  • Yoon, Sung Hwa;
  • Lee, Eunhwa;
  • Cho, Duk Yeon;
  • Ko, Hyun Myung;
  • Baek, Ha Yeon;
  • Choi, Dong Kug;
  • Kim, Eunha;
  • Park, Ju Young
  • 2021-03-15
  • Bioorganic and Medicinal Chemistry Letters, Vol.36
  • Elsevier Ltd
Design, synthesis, and biological evaluation of N-arylpiperazine derivatives as interferon inducersoa mark
  • Chu, Yeonjeong;
  • Raja Sekhara Reddy, B.;
  • Pratap Reddy Gajulapalli, V.;
  • Sudhakar Babu, K.;
  • Kim, Eunha;
  • Lee, Sanghee
  • 2020-12-15
  • Bioorganic and Medicinal Chemistry Letters, Vol.30 No.24
  • Elsevier Ltd
1